GPs expecting specialist rights for ‘2 per cent-plus' cannabis products

Website intended for a NZ health professional readership

+News

In print

Summer Hiatus

GPs expecting specialist rights for ‘2 per cent-plus' cannabis products

Simon

Maude

smaude@nzdoctor.co.nz

Monday 6 January 2020, 09:00 AM

We are on our summer break and the editorial office is closed until 13 January. We hope you enjoy this article which is part of Summer Hiatus, an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading

Kiwi medicinal cannabis companies got fired up this year, and GPs will soon find it easy to prescribe the products. Simon Maude reports on the emergin, Graham Gulbransen 2017, Auckland GP Graham Gulbransen, who specialises in addiction, says he is comfortable with changes to medicinal cannabis regulations

Cannabis

Prescribing

General Practice

GPs

News archive

How to Treat

+How to treat

Heart failure

Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality

Wednesday 29 January 2025, 12:45 AM